BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025
BioHarvest Sciences (NASDAQ: BHST), a pioneer in Botanical Synthesis technology, will present at the Canaccord Genuity 45th Annual Growth Conference from August 12-14, 2025, in Boston, Massachusetts.
CEO Ilan Sobel will conduct one-on-one meetings with institutional investors and deliver a corporate presentation on Tuesday, August 12, 2025, at 11:00 a.m. Eastern time at the InterContinental Boston Hotel. The presentation will highlight the company's growth momentum across its consumer and CDMO businesses.
BioHarvest Sciences (NASDAQ: BHST), pioniere nella tecnologia di Sintesi Botanica, parteciperà alla 45ª Conferenza Annuale sulla Crescita di Canaccord Genuity dal 12 al 14 agosto 2025 a Boston, Massachusetts.
Il CEO Ilan Sobel terrà incontri individuali con investitori istituzionali e presenterà una presentazione aziendale martedì 12 agosto 2025 alle 11:00 ora orientale presso l'InterContinental Boston Hotel. La presentazione metterà in evidenza lo slancio di crescita dell'azienda nei suoi settori consumer e CDMO.
BioHarvest Sciences (NASDAQ: BHST), pionera en la tecnología de Síntesis Botánica, presentará en la 45ª Conferencia Anual de Crecimiento de Canaccord Genuity del 12 al 14 de agosto de 2025 en Boston, Massachusetts.
El CEO Ilan Sobel realizará reuniones individuales con inversores institucionales y ofrecerá una presentación corporativa el martes 12 de agosto de 2025 a las 11:00 a.m., hora del Este en el Hotel InterContinental Boston. La presentación destacará el impulso de crecimiento de la empresa en sus negocios de consumo y CDMO.
BioHarvest Sciences (NASDAQ: BHST)는 식물 합성 기술 분야의 선구자로서, 2025년 8월 12일부터 14일까지 매사추세츠주 보스턴에서 열리는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에 참가합니다.
CEO 일란 소벨은 기관 투자자들과 일대일 미팅을 진행하며, 2025년 8월 12일 화요일 동부 시간 오전 11시에 인터컨티넨탈 보스턴 호텔에서 기업 발표를 할 예정입니다. 발표에서는 소비자 및 CDMO 사업 전반에 걸친 회사의 성장 모멘텀을 강조할 것입니다.
BioHarvest Sciences (NASDAQ : BHST), pionnier de la technologie de synthèse botanique, participera à la 45e conférence annuelle sur la croissance de Canaccord Genuity du 12 au 14 août 2025 à Boston, Massachusetts.
Le PDG Ilan Sobel tiendra des rencontres individuelles avec des investisseurs institutionnels et présentera une conférence d'entreprise le mardi 12 août 2025 à 11h00, heure de l'Est à l'hôtel InterContinental Boston. La présentation mettra en avant la dynamique de croissance de l'entreprise dans ses activités grand public et CDMO.
BioHarvest Sciences (NASDAQ: BHST), ein Pionier der botanischen Synthesetechnologie, wird auf der 45. jährlichen Wachstumskonferenz von Canaccord Genuity vom 12. bis 14. August 2025 in Boston, Massachusetts, vertreten sein.
CEO Ilan Sobel wird Einzelgespräche mit institutionellen Investoren führen und am Dienstag, den 12. August 2025, um 11:00 Uhr Eastern Time im InterContinental Boston Hotel eine Unternehmenspräsentation halten. Die Präsentation wird die Wachstumstrends des Unternehmens in den Bereichen Konsumgüter und CDMO hervorheben.
- None.
- None.
Rehovot, Israel--(Newsfile Corp. - July 23, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the Canaccord Genuity 45th Annual Growth Conference taking place on August 12-14, 2025 in Boston, Massachusetts.
CEO Ilan Sobel is scheduled to host one-on-one meetings with institutional investors throughout the event and will host a live BioHarvest Sciences corporate presentation as shown below.
Canaccord 45th Annual Growth Conference
Date: Tuesday, August 12, 2025
Presentation Time: 11:00 a.m. Eastern time
Location: InterContinental Boston Hotel | Boston, MA
Presentation Link: https://wsw.com/webcast/canaccord108/bhst/2520071
Sobel said: "We continue to build strong momentum across both our consumer and CDMO businesses, enabling us to derive the benefits of continued scaling of our business. I look forward to sharing further details of our growth plan at the Canaccord Growth Conference."
Online investors are invited to pre-register for the webcast presentation. For more information on the conference, or to schedule a one-on-one meeting with management, please contact MZ Group at BHST@mzgroup.us.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based compounds, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking novel plant-based compounds, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance of additional future contracts. Readers are cautioned that future contracts or increased revenue is not necessarily an increase in net income or profitability as costs will likely increase as well. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
(604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
BHST@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259761
FAQ
When is BioHarvest Sciences (BHST) presenting at the Canaccord Growth Conference 2025?
How can investors access BioHarvest Sciences' (BHST) Canaccord conference presentation?
Who will represent BioHarvest Sciences (BHST) at the Canaccord conference?
How can investors schedule meetings with BioHarvest Sciences (BHST) management at the conference?
